Join us for an engaging session that reviews the burden of Human Papillomavirus (HPV)-related disease and the vital role that vaccination plays in preventing multiple cancers. We’ll break down the 2025 updates to the provincial HPV immunization guidelines - highlighting new publicly funded eligibility, dosing changes, and scheduling recommendations – and explore what this means for your practice. Learn how your recommendation can make a difference in HPV prevention for clients of all genders, ages, and relationship contexts. Gain practical counselling tips, discover strategies to integrate vaccination seamlessly into your workflow, and explore opportunities to build partnerships that expand access to both publicly and privately funded HPV vaccines.
Learning Objectives
- Describe the burden of HPV-related disease and the role of vaccination in prevention of various cancers.
- Review the July 2025 changes to the BCCDC HPV immunization guidelines - including publicly funded eligibility, dosing, and scheduling recommendations.
- Recognize the important impact of a strong recommendation from a pharmacist in HPV prevention with clients of all genders, ages and partners, by applying practical tips and counselling strategies during client interactions.
- Explore how to integrate vaccination into routine pharmacy workflow and identify opportunities to build partnerships with organizations or service channels to provide both publicly and privately funded HPV vaccination.
About the Speaker: Jane Xia
Dr. Jane Xia joined the Faculty of Pharmaceutical Sciences in January 2019. She earned her Bachelor of Science in Pharmacy from the University of British Columbia, her MBA from Simon Fraser University, and her PharmD from the University of Toronto.
Dr. Xia has practiced in various areas of pharmacy, including community, hospital, regulatory, and industry settings. While working at Merck and Boehringer Ingelheim, she built strong, collaborative relationships with physicians and other healthcare professionals. In 2018, Dr. Xia and her team at London Drugs launched the Hepatitis C Screening Program in selected community pharmacies, following the successful establishment of partnerships with patient advocacy groups, healthcare teams, and specialists.
Dr. Xia’s current research interests include patient journeys in chronic diseases and business in healthcare, with a clinical focus on women’s health.
Learning Hours
This program is non-accredited. Total learning hours is estimated at 1.0 hours. Participants will receive a letter of participation after completion of the survey at the end of the webinar. This learning program received financial support from Merck. This event will be moderated by a member of our Pharmacy Practice Support team at the BC Pharmacy Association.
Registration Information
A BCPhA account is required to register for this event. If you do not have a login account or if you are unsure if you have a login, please fill out the Account Creation Form and a member of the BCPhA team will contact you. Accounts can be created free of charge with valid College registration.
Registration closes an hour prior to the start of the webinar, at 5:00 PM. On the day of the webinar, you will receive a link to the webinar by email. The email will come from noreply@zoom.us and could be in your junk folder.